From owner-watcher-work@jp.FreeBSD.org Tue Mar 26 05:20:38 2013
Received: (from daemon@localhost)
	by castle.jp.FreeBSD.org (8.11.6p2+3.4W/8.11.3) id r2PKKc788249;
	Tue, 26 Mar 2013 05:20:38 +0900 (JST)
	(envelope-from owner-watcher-work@jp.FreeBSD.org)
Received: from cable-178-148-43-178.dynamic.sbb.rs (cable-178-148-43-178.dynamic.sbb.rs [178.148.43.178])
	by castle.jp.FreeBSD.org (8.11.6p2+3.4W/8.11.3) with ESMTP/inet id r2PKK8J88167;
	Tue, 26 Mar 2013 05:20:08 +0900 (JST)
	(envelope-from smoothesu31@www.wbbse.com)
Received: from [178.148.43.178] (port=4802 helo=jelavasic)
	by nullmx.www.wbbse.com with asmtp 
	id 6D9C3B-000549-04
	for <shiba@jp.freebsd.org>; Mon, 25 Mar 2013 21:19:15 +0100
Message-ID: <0E52D0E7423D42DBBBD0E4148E045172@jelavasic>
From: "Manuela Hadley" <smoothesu31@www.wbbse.com>
To: <shiba@jp.FreeBSD.org>
MIME-Version: 1.0
Content-Type: text/plain;
	format=flowed;
	charset="iso-8859-1";
	reply-type=original
Content-Transfer-Encoding: 7bit
X-Priority: 3
X-MSMail-Priority: Normal
X-Mailer: Microsoft Windows Mail 6.0.6001.18000
X-MimeOLE: Produced By Microsoft MimeOLE V6.0.6001.18049
X-Mras: Ok
Reply-To: watcher-work@jp.FreeBSD.org
Precedence: list
Date: Mon, 25 Mar 2013 21:19:15 +0100
X-Sequence: watcher-work 17280
Subject: [watcher-work 17280] The World Of Medicinal Weed
Sender: owner-watcher-work@jp.FreeBSD.org
X-Originator: smoothesu31@www.wbbse.com
X-Distribute: distribute version 2.1 (Alpha) patchlevel 24e+060209

The November 2012 elections counted 18 states electing to legalize marijuana for medicinal purposes and two states decriminalizing recreational use. While it may not be traded on Wall Street any time soon, weed has become a booming cash crop.

A patient based leading U.S. company will target its researches to newly diagnosed patients infected with drug resistant virus, treatment experienced patients with drug-resistant HIV strains, and those intolerant of currently available therapies. The company may unlock the future of biotech and medicine. It may seem to be a gamble for some investors, but for those who have bolder minds and wish to invest in high reward ventures, the company is an investment that may be the key to unlock the future of biotechnology and medicine.

The Company works with leading experts in HIV and cancer drug development, medicinal characterization, and clinical research to develop, produce, and commercialize phytocannabinoid-based pharmaceutical products.

ATTENTION to medical and health care investors:

We are looking for industry leading ambitious investors who eager improve the lives of the peoples.



For further information, please visit   www.scientfc4all.com

To unsubscribe, visit  www.4allscientfc.com

